rs258751

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000176.3(NR3C1):​c.2034C>T​(p.Asp678Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00945 in 1,612,806 control chromosomes in the GnomAD database, including 591 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.036 ( 272 hom., cov: 31)
Exomes 𝑓: 0.0067 ( 319 hom. )

Consequence

NR3C1
NM_000176.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0830

Publications

22 publications found
Variant links:
Genes affected
NR3C1 (HGNC:7978): (nuclear receptor subfamily 3 group C member 1) This gene encodes glucocorticoid receptor, which can function both as a transcription factor that binds to glucocorticoid response elements in the promoters of glucocorticoid responsive genes to activate their transcription, and as a regulator of other transcription factors. This receptor is typically found in the cytoplasm, but upon ligand binding, is transported into the nucleus. It is involved in inflammatory responses, cellular proliferation, and differentiation in target tissues. Mutations in this gene are associated with generalized glucocorticoid resistance. Alternative splicing of this gene results in transcript variants encoding either the same or different isoforms. Additional isoforms resulting from the use of alternate in-frame translation initiation sites have also been described, and shown to be functional, displaying diverse cytoplasm-to-nucleus trafficking patterns and distinct transcriptional activities (PMID:15866175). [provided by RefSeq, Feb 2011]
NR3C1 Gene-Disease associations (from GenCC):
  • glucocorticoid resistance
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 5-143282715-G-A is Benign according to our data. Variant chr5-143282715-G-A is described in ClinVar as Benign. ClinVar VariationId is 351367.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.083 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NR3C1NM_000176.3 linkc.2034C>T p.Asp678Asp synonymous_variant Exon 8 of 9 ENST00000394464.7 NP_000167.1 P04150-1F1D8N4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NR3C1ENST00000394464.7 linkc.2034C>T p.Asp678Asp synonymous_variant Exon 8 of 9 1 NM_000176.3 ENSP00000377977.2 P04150-1

Frequencies

GnomAD3 genomes
AF:
0.0358
AC:
5409
AN:
151276
Hom.:
275
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.108
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0110
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0716
Gnomad SAS
AF:
0.0108
Gnomad FIN
AF:
0.0229
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00100
Gnomad OTH
AF:
0.0237
GnomAD2 exomes
AF:
0.0166
AC:
4176
AN:
250894
AF XY:
0.0145
show subpopulations
Gnomad AFR exome
AF:
0.110
Gnomad AMR exome
AF:
0.00620
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0702
Gnomad FIN exome
AF:
0.0205
Gnomad NFE exome
AF:
0.000821
Gnomad OTH exome
AF:
0.00817
GnomAD4 exome
AF:
0.00672
AC:
9824
AN:
1461458
Hom.:
319
Cov.:
32
AF XY:
0.00641
AC XY:
4659
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.109
AC:
3661
AN:
33450
American (AMR)
AF:
0.00718
AC:
321
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.0699
AC:
2772
AN:
39670
South Asian (SAS)
AF:
0.00907
AC:
782
AN:
86228
European-Finnish (FIN)
AF:
0.0194
AC:
1034
AN:
53344
Middle Eastern (MID)
AF:
0.00850
AC:
49
AN:
5768
European-Non Finnish (NFE)
AF:
0.000397
AC:
441
AN:
1111792
Other (OTH)
AF:
0.0127
AC:
764
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
457
915
1372
1830
2287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0357
AC:
5410
AN:
151348
Hom.:
272
Cov.:
31
AF XY:
0.0359
AC XY:
2654
AN XY:
73894
show subpopulations
African (AFR)
AF:
0.108
AC:
4467
AN:
41232
American (AMR)
AF:
0.0109
AC:
166
AN:
15202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.0715
AC:
370
AN:
5172
South Asian (SAS)
AF:
0.0105
AC:
50
AN:
4784
European-Finnish (FIN)
AF:
0.0229
AC:
236
AN:
10296
Middle Eastern (MID)
AF:
0.0139
AC:
4
AN:
288
European-Non Finnish (NFE)
AF:
0.00100
AC:
68
AN:
67906
Other (OTH)
AF:
0.0235
AC:
49
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
239
479
718
958
1197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0110
Hom.:
218
Bravo
AF:
0.0377
Asia WGS
AF:
0.0530
AC:
183
AN:
3478
EpiCase
AF:
0.000546
EpiControl
AF:
0.00113

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glucocorticoid resistance Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NR3C1-related disorder Benign:1
Jul 09, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
8.2
DANN
Benign
0.45
PhyloP100
-0.083
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs258751; hg19: chr5-142662280; COSMIC: COSV51543226; API